Multicenter Comparison of Interictal HFO as a Predictor of Seizure Freedom

Enrolling by invitationOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

May 1, 2022

Primary Completion Date

May 1, 2024

Study Completion Date

May 1, 2024

Conditions
Epilepsy Intractable
Interventions
DIAGNOSTIC_TEST

HFO analysis

We use an automated data-independent prospective definition of clinically relevant HFO that has been validated in data from two independent epilepsy centers.

Trial Locations (1)

8091

University Hospital Zurich, Neurosurgery, Zurich

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

McGill University

OTHER

collaborator

University of Michigan

OTHER

collaborator

University of Calgary

OTHER

collaborator

Cook Children's Health Care System

OTHER

collaborator

St. Anne's University Hospital Brno, Czech Republic

OTHER

collaborator

Mayo Clinic

OTHER

collaborator

Thomas Jefferson University

OTHER

collaborator

UMC Utrecht

OTHER

collaborator

Schweizerisches Epilepsie Zentrum

UNKNOWN

lead

University of Zurich

OTHER

NCT05332990 - Multicenter Comparison of Interictal HFO as a Predictor of Seizure Freedom | Biotech Hunter | Biotech Hunter